Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study

Han Kwang-Hyub; Kim Do Young; Park Jun Yong; Ahn Sang Hoon; Kim Jieun; Kim Seung Up; Kim Ja Kyung; Lee Kwan Sik; Chon Chae Yoon

首页> 外文期刊>Journal of clinical gastroenterology >Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study

【24h】

Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study

机译：与超过6个月相比，肝细胞癌患者的存活率可能在监测间隔内不超过6个月进行改善：一个15年的前瞻性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Goals:

机译：目标：

著录项

来源
《Journal of clinical gastroenterology》 |2013年第6期|共7页
作者
Han Kwang-Hyub; Kim Do Young; Park Jun Yong; Ahn Sang Hoon; Kim Jieun; Kim Seung Up; Kim Ja Kyung; Lee Kwan Sik; Chon Chae Yoon;
展开▼
作者单位

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Biostat Collaborat Units Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

Yonsei Univ Coll Med Dept Internal Med Seoul 120752 South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
hepatocellular carcinoma; surveillance; screening; survival;

机译：肝细胞癌;监测;筛选;生存;

相似文献

外文文献
中文文献
专利

1. Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study [J] . Han Kwang-Hyub, Kim Do Young, Park Jun Yong, Journal of clinical gastroenterology . 2013,第6期

机译：与超过6个月相比，肝细胞癌患者的存活率可能在监测间隔内不超过6个月进行改善：一个15年的前瞻性研究
2. Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching [J] . David E. Kaplan, Rajni Mehta, Kathryn D’Addeo, Journal of vascular and interventional radiology: JVIR . 2018,第4Suppla期

机译：索拉非尼在前3个月内的常规化疗栓塞改善了肝细胞癌的整体存活：一种回顾性，多制度研究，具有倾向匹配
3. Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching [J] . Kaplan David E., Mehta Rajni, DAddeo Kathryn, Journal of vascular and interventional radiology: JVIR . 2018,第4期

机译：索拉非尼在前3个月内的常规化疗栓塞改善了肝细胞癌的整体存活：一种回顾性，多制度研究，具有倾向匹配
4. Results after nine months of a prospective randomized study comparing transurethral resection of the prostate and visual laser ablation of the prostate [C] . Robert S. Cowles, M.D., The Urology Clinic, Lasers in Urology, Gynecology, and General Surgery . 1993

机译：九个月的前瞻性随机研究结果比较了经尿道前列腺电切术和前列腺视觉激光消融术
5. Results of a randomized, controlled trial to assess the toxicity and patient adherence with two short-course regimens for the prevention of tuberculosis, a two-month regimen of rifampin and pyrazinamide or a four-month regimen of rifampin only, in comparison with a control regimen of six-months-isoniazid. [D] . Geiter, Lawrence James. 1997

机译：与对照相比，采用两种短期疗程预防结核病，两个月利福平和吡嗪酰胺治疗或仅四个月利福平治疗，评估毒性和患者依从性的随机对照试验结果六个月异烟肼的治疗方案。
6. Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective Multi-Institutional Study with Propensity Matching [O] . David E. Kaplan, Rajni Mehta, Kathryn D’Addeo, -1

机译：索拉非尼启动后头三个月内的经动脉化学栓塞治疗可改善肝细胞癌的总体生存率：一项具有倾向性匹配的回顾性多机构研究
7. Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching [O] . David E. Kaplan, Rajni Mehta, Kathryn D’Addeo, 2018

机译：在索拉非尼的前3个月内rantarterial Chemoembolization提高了肝细胞癌的整体存活：回顾性，多制度研究，具有倾向匹配

Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study

摘要

著录项

相似文献

相关主题

期刊订阅